|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.07 USD | -1.76% |
|
+10.43% | -48.44% |
| 07-02 | Scinai Immunotherapeutics Ltd. Provides Earnings Guidance for 2024 | CI |
| 07-02 | Scinai Immunotherapeutics Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Scinai Immunotherapeutics Ltd. provided earnings guidance for 2024. For the period, the company maintained sales guidance of $1.25 million in expected revenues.
| 1st Jan change | Capi. | |
|---|---|---|
| -48.44% | 1.43M | |
| +18.97% | 45.34B | |
| +41.98% | 40.42B | |
| -10.06% | 37.92B | |
| +31.15% | 31.75B | |
| -7.79% | 27.71B | |
| +13.32% | 26.52B | |
| +43.05% | 13.96B | |
| +31.28% | 12.44B | |
| -7.41% | 11.26B |
SCINAI IMMUNOTHERAPEUTICS LTD. 
